Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271842 | PMC |
| http://dx.doi.org/10.1016/j.jaad.2020.05.147 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Creating an Empirical Dermatology Dataset Through Crowdsourcing With Web Search Advertisements.
JAMA Netw Open
November 2024
Google Research, Amsterdam, Netherlands.
Importance: Health datasets from clinical sources do not reflect the breadth and diversity of disease, impacting research, medical education, and artificial intelligence tool development. Assessments of novel crowdsourcing methods to create health datasets are needed.
Objective: To evaluate if web search advertisements (ads) are effective at creating a diverse and representative dermatology image dataset.
Dermatology-related quality-of-life outcomes in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab (Pmab) maintenance after FOLFOX + Pmab induction: a prespecified secondary analysis of the phase II randomized PanaMa (AIO KRK 0212) trial.
ESMO Open
July 2024
Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology, and Cancer Immunology (CVK/CCM), Berlin; German Cancer Consortium (DKTK), German Cancer Research Centre (DKFZ), Heidelberg.
Background: The key endpoints for the assessment of the effect of maintenance therapy for metastatic colorectal cancer (mCRC) are survival and quality-of-life outcomes. We aimed to compare dermatology-related quality of life (DRQOL) in patients with RAS wild-type (wt) mCRC treated with fluorouracil and folinic acid (FU/FA) + panitumumab (Pmab) versus FU/FA alone as maintenance therapy after folinic acid, fluorouracil and oxaliplatin + Pmab induction.
Patients And Methods: The phase II randomized PanaMa (AIO KRK 0212; NCT01991873) trial included 387 patients at 70 community/academic sites in Germany.
Global Scientific Overview of Dermatology Related to COVID-19: A Bibliometric Analysis.
Indian J Dermatol
February 2024
Vicerrectorado de Investigación, Universidad San Ignacio de Loyola, Lima, Peru.
Background: Coronavirus disease 2019 (COVID-19) has had a significant impact on dermatology, but to date no bibliometric analysis of this field has been identified. Therefore, the aim of this study was to perform a bibliometric indicator analysis of the worldwide scientific production of COVID-19 in dermatology.
Materials And Methods: An advanced bibliographic search was performed in the Scopus database to identify articles on COVID-19 and dermatology from 2020 to 2021.
An Analysis of Dermatology-Related Red-Light Therapy Patient Questions on Reddit.
Dermatol Surg
June 2024
Department of Dermatology, State University of New York, Downstate Health Sciences University, Brooklyn, New York.
Background: Reddit is one of the world's most popular social media platforms and is increasingly used as a health information resource for patients on topics such as red-light (RL) therapy.
Objective: In this article, the authors present an analysis of prevalent patient questions and concerns regarding RL therapy.
Methods: All posts on the "Hot" page of the r/redlighttherapy subreddit were analyzed and categorized.
Current State of Dermatology Mobile Applications With Artificial Intelligence Features.
JAMA Dermatol
June 2024
Dermatology Services, Memorial Sloan Kettering Cancer Center, New York, New York.
Article Synopsis
- Advances in mobile tech and AI have led to a rise in dermatology apps for consumers, but evidence supporting their effectiveness is limited.
- A study analyzed 909 AI dermatology apps, narrowing it down to 41 after reviewing their purpose, evidence, regulatory status, and data privacy.
- Findings showed that none of the apps were FDA-approved, and most lacked clinician input and transparency, raising concerns about their reliability and safety for consumers.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!